Navigation Links
New Study Suggests Tapentadol IR for Acute Pain Is Associated With Improved Gastrointestinal Tolerability Compared to Oxycodone IR
Date:5/9/2008

tients with low back pain or pain from osteoarthritis of the knee or hip studied the tolerability of long-term exposure (90-days) to tapentadol IR. Patients were randomly assigned in a 4:1 ratio to a flexible dose of either tapentadol IR (50 or 100 mg/dose; maximum 600 mg/day) or oxycodone IR (10 or 15 mg/dose; maximum 90 mg/day) every four to six hours.

J&JPRD and Grunenthal GmbH supported this study.

J&JPRD and Ortho-McNeil-Janssen Pharmaceuticals, Inc. are wholly owned subsidiaries of Johnson & Johnson.

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Johnson & Johnson Pharmaceutical Research & Development, L.L.C., (J&JPRD) is a wholly owned subsidiary of Johnson & Johnson, the world's most broadly based producer of health care products. J&JPRD is headquartered in Raritan, N.J., and has facilities throughout Europe, the United States and Asia. J&JPRD is leveraging drug discovery and drug development in a variety of therapeutic areas, including CNS, Internal Medicine and Oncology, to address unmet medical needs worldwide. More information can be found at http://www.jnjpharmarnd.com/.

PriCara(TM), Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc.

PriCara(TM), a Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., is a major health care company in the United States dedicated to the needs of primary care providers who serve a vital role on the frontline of medicine. For more information about the company, please visit http://www.PriCara.com.

Grunenthal

Grunenthal, a privately owned pharmaceutical company based in Aachen, Germany, discovered and started development of tapentadol. Grunenthal and J&JPRD have shared development responsibilities for tapentadol for acute and chronic pain conditions since the companies signed a licensing agreement for tapentadol in 2003.


'/>"/>

SOURCE Johnson & Johnson Pharmaceutical Research & Development,L.L.C.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. New Data From Phase 3 Study Suggests Tapentadol Immediate Release Effective for Acute Pain From Common Foot Surgery
2. New Study Demonstrates ACTEMRA(R) (tocilizumab) Inhibits Progression of Joint Damage in Rheumatoid Arthritis Patients
3. Results of the Phase III Pivotal Study of VYVANSE(TM) (Lisdexamfetamine Dimesylate) for the Treatment of ADHD in Adults Presented at National Scientific Meeting of Psychiatrists
4. Skin Flaps Deliver Cancer-fighting Therapy, ASPS Study Reveals
5. Data from Randomized Pilot Study, Real-World Use of OrbusNeichs Genous(TM) Bio-engineered R stent(TM) to be Presented in Symposium at EuroPCR 2008
6. Bayer and Regeneron Dose First Patient in Second Phase 3 Study for VEGF Trap-Eye in Wet Age-Related Macular Degeneration
7. Trubion Announces Initiation of Phase 2b Study of TRU-015 for the Treatment of Rheumatoid Arthritis
8. Study Demonstrates Lexapro(R) Significantly Improves Depression Symptoms in Adolescents
9. Patients Treated with Risperidone Long-Acting Injection had a Significantly Longer Time to Relapse Compared to Quetiapine in International Clinical Study
10. PEAK Surgical Announces Positive Results From Preclinical Study of PEAK PlasmaBlade(TM) for Obstetric and Gynecologic Surgery
11. New Study Confirms Dose-Accuracy of SoloSTAR(R) Prefilled Insulin Pen
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)... -- Dr. Mark Rasak , MD is recognized by ... in the field of Medicine as a result of ... Dr. Rasak has over 15 years of experience ... business; overseeing the daily operations; interventional cardiology; complex coronary ... he is an honored Fellow of the American Board ...
(Date:8/22/2014)... , Cali ., Aug. 22, 2014 /PRNewswire/ ... Conference shows that a therapy being developed by Hera Therapeutics ... that cause 70 percent of all cervical cancer. ... the replication of HPV-16, HPV-18 and HPV-11 cells, according to ... , Ph.D., who presented the findings at the ...
(Date:8/22/2014)... , Aug. 22, 2014 /PRNewswire/ - SQI ... that develops and commercializes proprietary technologies and products ... has entered into a Master Service Agreement to ... DNA-based pathogen detection assays. During the initial phase ... deliver an automated working prototype of one of ...
Breaking Medicine Technology:Dr. Mark Rasak, MD is recognized by Continental Who's Who with the Diamond Lifetime Achievement Award 2Study shows Hera Therapeutics experimental compound shuts down human papillomavirus that causes most cervical cancer 2SQI Diagnostics Contracted to Automate Pathogen Detection Assays 2SQI Diagnostics Contracted to Automate Pathogen Detection Assays 3
... 16, 2011 The largest human dermal allograft available on ... be introduced at the AWR meeting here this week.  The ... introducing FlexHD acellular hydrated dermal matrix 20 cm ... x 25 cm grafts. FlexHD large ...
... June 16, 2011 Reata Pharmaceuticals , Inc. and ... clinical trial to evaluate the safety and efficacy of bardoxolone methyl ... and type 2 diabetes. The trial, known as BEACON ... with C hronic kidney disease and type 2 diabetes: the ...
Cached Medicine Technology:Largest Acellular Dermal Allografts Available for Abdominal Wall Reconstruction Introduced at AWR 2011 2Reata and Abbott Initiate Global Phase 3 Study of Bardoxolone Methyl in Patients With Chronic Kidney Disease and Type 2 Diabetes 2Reata and Abbott Initiate Global Phase 3 Study of Bardoxolone Methyl in Patients With Chronic Kidney Disease and Type 2 Diabetes 3
(Date:8/22/2014)... August 22, 2014 Restore My ... and Dr. Samantha Pearson to help people discover how ... corrective vision surgery by instead improving their eyesight naturally ... investigative review. , “There’s a reason why the ... revenue each year—it’s because people just assume that it’s ...
(Date:8/22/2014)... CarePoint Health is proud to ... Geriatrics, Hospice and Palliative Care, Dr. Michelle Reisner, ... Their system welcomes Dr. Reisner to the community. ... CarePoint Health Medical Group, a comprehensive network of ... a wide range of specialties. This latest acquisition ...
(Date:8/22/2014)... Dayton Children's Hospital broke ground on a historic new, ... million campus renewal. Renderings of the exterior ... public. , The new patient tower is part of ... that meets the needs of patients, families and care providers ... Dayton Children’s unique patient care mission and offer places that ...
(Date:8/22/2014)... CO (PRWEB) August 22, 2014 ... provider of in-home care for seniors, is proud to ... Webinar Series. The upcoming webinar will feature Dr. Suzanne ... at Lenox Hill Hospital in New York City, National ... and author. The webinar will cover the issues surrounding ...
(Date:8/22/2014)... Aug. 22, 2014 (HealthDay News) -- College can be a ... of things they can do to make the most of ... time to adjust, explore, meet new people and learn to ... of student wellness and assessment at St. John,s University in ... "Not all learning takes place in the classroom. College is ...
Breaking Medicine News(10 mins):Health News:Restore My Vision Today: Review Exposes Natural Eye Restoration Guide by Dr. Sen and Dr. Samantha Pearson 2Health News:Dr. Reisner Joins CarePoint Health Medical Group 2Health News:Dayton Children's Hospital Breaks Ground on New, Eight-story Patient Care Tower 2Health News:Dayton Children's Hospital Breaks Ground on New, Eight-story Patient Care Tower 3Health News:Dayton Children's Hospital Breaks Ground on New, Eight-story Patient Care Tower 4Health News:Dayton Children's Hospital Breaks Ground on New, Eight-story Patient Care Tower 5Health News:Home Care Assistance of Centennial to Host Webinar on Heart Health, Featuring Dr. Suzanne Steinbaum 2Health News:Home Care Assistance of Centennial to Host Webinar on Heart Health, Featuring Dr. Suzanne Steinbaum 3Health News:College Prep 101 2
... the central government for denying medicos salaries for the ... higher educational institutions, and asked it to be a ... attitude of the government, a bench of judges Arijit ... Vahanvati: "you should act like a model employer. When ...
... pig fever had been diagnosed and was the cause of ... believed to be the first reported case of the disease ... the death of pigs by the Indian Veterinary Research Institute ... Divakaran. ,Reports indicate that initially the owner of ...
... There seems to be a link between the oft occurring ... ,Medical records of more than 4000 patients, below ... by British researchers .It was observed that those who had ... % tendency of developing Type 1 diabetes. ,Simon O'Neill, ...
... Using mice as an experimental animal, researchers have discovered that ... oocytes (egg) supply in their ovaries//. ,As a ... discoveries in the field of ovarian stem cell research and ... Henry's Institute and Associate Professor Jeff Kerr from Monash's Department ...
... public health emergency crisis. It is a rising killer in ... year about 5,000 people die prematurely in Canada's 11 largest ... Canada than breast cancer, prostate cancer, or motor vehicle accidents. ... quality index (AQI) in Hamilton was 67. On an average ...
... obesity-related risk factors have indicated that more the women ... risks// like hypertension, diabetes and hypercholesterolemia. ,Especially ... predisposing women to major health risks – researchers reported ... treatment are typically based on body mass index (BMI) ...
Cached Medicine News:Health News:Government Pulled up for Denying Pay to Striking Medicos 2Health News:Renewable Oocytes of Mice created hope in Human Fertility Treatment 2Health News:Obese Women are more likely to suffer from Major Health Risks 2Health News:Obese Women are more likely to suffer from Major Health Risks 3
Cannulated Interference Screws...
... Endoscopy Components, LLC offers ... Equipment "Made in Germany". ... manufactured according to ISO ... most excellent design elements ...
... provide excellent protection and ease of use. ... closer to an adhesive in molecular weight ... to maintain viscosity at high shear rates, ... for superb performance during capsulorhexis, phaco, IOL ...
... moisturizing mist for the eyes developed with ... from Oregon Health Sciences University's Casey Eye ... (2000) and dry eye patients showed, on ... volume of the eyes' tear film without ...
Medicine Products: